You are here

Article info

Article menu

Download PDFPDF

Case Report
Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade

Authors

  • Heinz Läubli Department of Internal Medicine, Division of Medical OncologyUniversity Hospital Basel Basel Switzerland Department of Biomedicine, Cancer Immunology LaboratoryUniversity Hospital Basel Basel Switzerland Medical Oncology and Cancer ImmunologyUniversity Hospital Basel Petersgraben 4 4031 Basel Switzerland PubMed articlesGoogle scholar articles
  • Jürgen Hench Department of Pathology, Division of NeuropathologyUniversity Hospital Basel Basel Switzerland PubMed articlesGoogle scholar articles
  • Michal Stanczak Department of Internal Medicine, Division of Medical OncologyUniversity Hospital Basel Basel Switzerland Department of Biomedicine, Cancer Immunology LaboratoryUniversity Hospital Basel Basel Switzerland PubMed articlesGoogle scholar articles
  • Ingmar Heijnen Department of Laboratory MedicineUniversity Hospital Basel Basel Switzerland PubMed articlesGoogle scholar articles
  • Alexandros Papachristofilou Department of Radiology, Division of RadiotherapyUniversity Hospital Basel Basel Switzerland PubMed articlesGoogle scholar articles
  • Stephan Frank Department of Pathology, Division of NeuropathologyUniversity Hospital Basel Basel Switzerland PubMed articlesGoogle scholar articles
  • Alfred Zippelius Department of Internal Medicine, Division of Medical OncologyUniversity Hospital Basel Basel Switzerland Department of Biomedicine, Cancer Immunology LaboratoryUniversity Hospital Basel Basel Switzerland PubMed articlesGoogle scholar articles
  • Frank Stenner-Liewen Department of Internal Medicine, Division of Medical OncologyUniversity Hospital Basel Basel Switzerland Department of Biomedicine, Cancer Immunology LaboratoryUniversity Hospital Basel Basel Switzerland PubMed articlesGoogle scholar articles

Citation

Läubli H, Hench J, Stanczak M, et al
Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade
Journal for ImmunoTherapy of Cancer 2017;5:46. doi: 10.1186/s40425-017-0249-y
Online issue publication 
February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.